Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy C4 Therapeutics stock in Canada
Own C4 Therapeutics shares in just a few minutes.
C4 Therapeutics is a biotechnology business based in the US. C4 Therapeutics stocks (CCCC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $39.67 – an increase of 1.59% over the previous week. C4 Therapeutics employs 99 staff and has a trailing 12-month revenue of around $34 million.
How to buy shares in C4 Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CCCC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy C4 Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
C4 Therapeutics stock price (NASDAQ:CCCC)Use our graph to track the performance of CCCC stocks over time.
C4 Therapeutics shares at a glance
|Latest market close||$27.54|
|52-week range||$26.39 - $51.21|
|50-day moving average||$36.98|
|200-day moving average||$39.10|
|Wall St. target price||$60.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.81|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
C4 Therapeutics price performance over time
|1 week (2022-01-07)||1.59%|
|1 month (2021-12-16)||-9.70%|
|3 months (2021-10-15)||-37.25%|
|6 months (2021-07-16)||-31.06%|
|1 year (2021-01-15)||-28.11%|
|2 years (2020-01-12)||N/A|
|3 years (2019-01-12)||N/A|
|5 years (2017-01-12)||N/A|
C4 Therapeutics financials
|Revenue TTM||$34 million|
|Gross profit TTM||$-44,273,000|
|Return on assets TTM||-14.55%|
|Return on equity TTM||-36.06%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
C4 Therapeutics share dividends
We're not expecting C4 Therapeutics to pay a dividend over the next 12 months.
C4 Therapeutics overview
C4 Therapeutics, Inc. , a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in preclinical stage targeting IKZF1/3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; and BRAF V600E to treat melanoma, non-small cell lung cancer, colorectal cancer, and other solid malignancies, as well as RET to treat lung cancer, sporadic medullary thyroid cancers, and other solid malignancies. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffman-La Roche Ltd.
Stocks similar to C4 Therapeutics
Frequently asked questions
C4 Therapeutics in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Is C4 Therapeutics, Inc. (CCCC) A Good Stock To Buy?
C4 Therapeutics (CCCC) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.